/PRNewswire/ Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today renewed its commitment to increasing awareness and advancing care for people living with TD.
Neurocrine joins in on Tardive Dyskinesia Awareness Week fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Iowa passed a bill to increase availability of E15, a critical component of increasing our energy independence and addressing climate change. And it’s Tardive Dyskinesia Awareness Week we explain what it is and why knowledge and R&D matter. (570 words, 2 minutes, 51 seconds)